Biodistribution and SPECT imaging study of 99mTc Labeling NGR peptide in nude mice bearing human HepG2 hepatoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ma, Wenhui ^a   Wang, Zhe ^a   Yang, Weidong ^a   Ma, Xiaowei ^a   Kang, Fei ^a   Wang, Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGYLGLYCYL ARGININE TC 99M; COLLOID TC 99M; MICROSOMAL AMINOPEPTIDASE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; NGR PEPTIDE; OLIGOPEPTIDE; TECHNETIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; FEMALE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER CELL CARCINOMA; MOUSE; MUSCLE; NONHUMAN; PROTEIN EXPRESSION; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; CHEMISTRY; DIAGNOSTIC USE; EXPERIMENTAL NEOPLASM; METABOLIC CLEARANCE RATE; METABOLISM; NUDE MOUSE; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; FEMALE; HEP G2 CELLS; HUMANS; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; OLIGOPEPTIDES; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84902214724     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/618096     Document Type: Article

References (19)

1. Wang X., Wang Y., Chen X., Wang J., Zhang X., Zhang Q., NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells. Journal of Controlled Release 2009 139 1 56 62 2-s2.0-68949204885 10.1016/j.jconrel.2009.05.030
2. Zhao B.-J., Ke X.-Y., Huang Y., Chen X.-M., Zhao X., Zhao B.-X., Lu W.-L., Lou J.-N., Zhang X., Zhang Q., The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats. Journal of Drug Targeting 2011 19 5 382 390 2-s2.0-79955623052 10.3109/1061186X.2010.504267
3. Bhagwat S. V., Lahdenranta J., Giordano R., Arap W., Pasqualini R., Shapiro L. H., CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 2001 97 3 652 659 2-s2.0-0035254206 10.1182/blood.V97.3.652 (Pubitemid 32113397)
4. Negussie A. H., Miller J. L., Reddy G., Drake S. K., Wood B. J., Dreher M. R., Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. Journal of Controlled Release 2010 143 2 265 273 2-s2.0-77950337966 10.1016/j.jconrel.2009.12.031
5. 64Cu- labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Molecular Pharmacology 2013 10 1 417 427
6. Arap W., Pasqualini R., Ruoslahti E., Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998 279 5349 377 380 2-s2.0-0032535999 10.1126/science.279.5349.377 (Pubitemid 28063372)
7. Curnis F., Arrigoni G., Sacchi A., Fischetti L., Arap W., Pasqualini R., Corti A., Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Research 2002 62 3 867 874 2-s2.0-0036468937 (Pubitemid 34126966)
8. Dijkgraaf I., Yim C.-B., Franssen G. M., Schuit R. C., Luurtsema G., Liu S., Oyen W. J. G., Boerman O. C., PET imaging of α v β 3 integrin expression in tumours with68Ga-labelled mono-, di- and tetrameric RGD peptides. European Journal of Nuclear Medicine and Molecular Imaging 2011 38 1 128 137 2-s2.0-79551515411 10.1007/s00259-010-1615-x
9. Meng J., Yan Z., Xue X., Hao Q., Wan Y., Qin X., Zhang C., You Y., Han W., Zhang Y., High-yield expression, purification and characterization of tumor-targeted IFN- α 2a. Cytotherapy 2007 9 1 60 68 2-s2.0-34247177587 10.1080/14653240601094322 (Pubitemid 46992968)
10. 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. Nuclear Medicine and Biology 2006 33 3 371 380 2-s2.0-33646050623 10.1016/j.nucmedbio.2005.12.011
11. Wang Z., Ma W., Wang J., Imaging and therapy of hSSTR2-transfected tumors using radiolabeled somatostatin analogs. Tumor Biology 2013 34 4 2451 2457
12. Adar L., Shamay Y., Journo G., David A., Pro-apoptotic peptide-polymer conjugates to induce mitochondrial-dependent cell death. Polymers for Advanced Technologies 2011 22 1 199 208 2-s2.0-78650706147 10.1002/pat.1829
13. 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Molecular Imaging and Biology 2012 14 1 96 105 2-s2.0-79951958259 10.1007/s11307-011-0479-1
14. 64Cu-labeled tetrameric RGD peptide. Journal of Nuclear Medicine 2005 46 10 1707 1718 2-s2.0-27944457471 (Pubitemid 46211595)
15. Ndinguri M. W., Solipuram R., Gambrell R. P., Aggarwal S., Hammer R. P., Peptide targeting of platinum anti-cancer drugs. Bioconjugate Chemistry 2009 20 10 1869 1878 2-s2.0-70350641403 10.1021/bc900065r
16. Corti A., Giovannini M., Belli C., Villa E., Immunomodulatory agents with antivascular activity in the treatment of non-small cell lung cancer: focus on TLR9 agonists, IMiDs and NGR-TNF. Journal of Oncology 2010 2010 8 2-s2.0-77954649329 10.1155/2010/732680 732680
17. Chen K., Conti P. S., Target-specific delivery of peptide-based probes for PET imaging. Advanced Drug Delivery Reviews 2010 62 11 1005 1022 2-s2.0-78649325858 10.1016/j.addr.2010.09.004
18. Ma W., Kang F., Wang Z., T c 99 m -labeled monomeric and dimeric NGR peptides for SPECT imaging of CD13 receptor in tumor-bearing mice. Amino Acids 2013 44 5 1337 1345
19. Samli K. N., McGuire M. J., Newgard C. B., Johnston S. A., Brown K. C., Peptide-mediated targeting of the islets of Langerhans. Diabetes 2005 54 7 2103 2108 2-s2.0-21344465167 10.2337/diabetes.54.7.2103 (Pubitemid 40911273)